Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127725351 | 12772535 | 1 | I | 20160914 | 20160922 | 20160922 | EXP | ES-MYLANLABS-2016M1039973 | MYLAN | SAFONT A, DONAZAR M, GASTON B, BARRENETXEA J, URTASUN M, GARCIA S, ET AL. FETAL SUPRAVENTRICULAR TACHYCARDIA IN A TRIPLET PREGNANCY. J-MATERN-FETAL-NEONAT-MED 2016;29:124-125. | 0.00 | Y | 0.00000 | 20160922 | OT | ES | ES |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127725351 | 12772535 | 1 | PS | DIGOXIN. | DIGOXIN | 1 | Oral | U | U | 40282 | |||||||||
127725351 | 12772535 | 2 | SS | DIGOXIN. | DIGOXIN | 1 | Intravenous (not otherwise specified) | U | U | 40282 | |||||||||
127725351 | 12772535 | 3 | SS | FLECAINIDE | FLECAINIDE | 1 | Oral | U | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127725351 | 12772535 | 1 | Product used for unknown indication |
127725351 | 12772535 | 3 | Supraventricular tachycardia |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127725351 | 12772535 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127725351 | 12772535 | Electrocardiogram ST segment depression | |
127725351 | 12772535 | Maternal exposure during pregnancy | |
127725351 | 12772535 | Premature delivery |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |